What You Missed
Why Attend the Fluid & Imaging Biomarkers in Neuroscience Summit?
Returned to Boston October 2025, the 3rd Fluid & Imaging Biomarkers in Neuroscience Summit is the only industry-led meeting dedicated exclusively to advancing biomarker discovery, validation, and clinical utility across neurodegenerative and neuroinflammatory diseases. With blood-based diagnostics like p-tau217 making headlines, but still far from sufficient, this year’s event convenes pioneers from Roche, Prothena, Eisai, and the Michael J. Fox Foundation to address the toughest translational hurdles. At the heart of the discussion will be the next generation of large-scale omics approaches, spanning genomics, proteomics, metabolomics, and beyond, that are driving the discovery of novel biomarker signatures and redefining how we validate disease mechanisms. Combined with innovations in high-sensitivity assays and imaging integration, omics is set to play a central role in shaping the future of smarter, faster biomarker development.
“Timely conference, great speakers, and networking activities helpful.”
ZelosDx
Top 5 Takeaways From the 2025 Summit:
- Watch as experts unlock and asses latest in large-scale omics, high-sensitivity assay platforms, and micro-sampling technologies that are reshaping how we discover and validate biomarkers
- Stay ahead of the curve by accessing exclusive insights on high-profile and next-generational biomarkers such as Endo lysosomes, inflammasomes, RNA signatures and preventative measures
- Learn about how other companies navigate clinical and regulatory bottlenecks, file for INDs and standardize data to accelerate approval and de-risk development
- A select number of encore and never-before-seen content unveiled exclusively at this summit, offering attendees an unmatched opportunity to gain early, actionable intelligence
- Join a curated community of leaders from academia, biotech, pharma, and tech, sparking ideas and cross-sector collaboration alongside powerhouses like Roche, Prothena, Eisai, and the Michael J. Fox Foundation
Join a highly engaged audience of senior decision-makers, spanning Directors, VPs, and C-Level leaders, from leading biotech and pharma companies, alongside top academic minds, and innovative solution providers, all driving the future of fluid and imaging biomarkers in neuroscience.
Who Attended
Don't Just Take Our Word For It...
“It is a unique setting with some of the best and up and coming tools for drug development to be discussed and advanced.”
FNIH
“The speed networking was fun and useful for ice breaking. Panel discussions were informative.”
Myrobalan Therapeutics
